Abstract
In order to explore the role of exosomal circRNAs in the occurrence and development of sepsis, we looked for potential diagnostic markers to accurately identify sepsis and to lay a molecular basis for precise treatment. Ultracentrifugation was used to extract exosomes from the serum of patients with sepsis and healthy individuals. Then, changes in circRNA expression in exosomes were studied by circRNA microarray analysis. Gene ontology (GO) analysis and Kyoto City Encyclopaedia of Genes and Genomes (KEGG) pathway analysis were used to annotate the biological functions and pathways of genes, and a circRNA-miRNA-mRNA regulatory network was constructed. In the microarray analysis, 132 circRNAs were significantly differentially expressed, including 80 and 52 that were upregulated and downregulated, respectively. RT-qPCR verified the results of microarray analysis: hsa_circRNA_104484 and hsa_circRNA_104670 were upregulated in sepsis serum exosomes. ROC analysis showed that hsa_circRNA_104484 and hsa_circRNA_104670 in serum exosomes have the potential to be used as diagnostic markers for sepsis. The circRNA-miRNA-mRNA network predicted the potential regulatory pathways of differentially expressed circRNAs. There are differences in the expression of circRNA in serum exosomes between patients with sepsis and healthy individuals, which may be involved in the occurrence and development of the disease. Among them, elevations in hsa_circRNA_104484 and hsa_circRNA_104670 could be used as novel diagnostic biomarkers and molecular therapeutic targets.
Introduction
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. It remains a major global health challenge and a leading cause of hospital mortality. Early diagnosis is critical for improving patient outcomes, yet clinical symptoms are often non-specific, and a definitive "gold standard" laboratory test is currently lacking.
Recent research has focused on exosomes—small extracellular vesicles (30–150 nm) that transport proteins, lipids, and nucleic acids between cells. Circular RNAs (circRNAs), characterized by their covalently closed loop structure, are particularly abundant and stable within exosomes. Unlike linear RNAs, circRNAs are resistant to exonuclease degradation, making them promising candidates for non-invasive liquid biopsies. This study investigates the expression profiles of exosomal circRNAs in sepsis patients to identify novel diagnostic biomarkers and therapeutic targets.
Methods
The study included 25 patients with sepsis (diagnosed per Sepsis-3 criteria) and 22 healthy controls from the Second Hospital of Jilin University. Exosomes were isolated from serum using ultracentrifugation. The purity and morphology of the isolated vesicles were confirmed through Transmission Electron Microscopy (TEM) and Western blot analysis for the exosomal markers CD63 and TSG101.
Following isolation, a circRNA microarray was employed to screen for differentially expressed circRNAs. Candidate molecules were subsequently validated in a larger cohort using RT-qPCR. Diagnostic performance was evaluated using Receiver Operating Characteristic (ROC) curves and Area Under the Curve (AUC) analysis. Finally, bioinformatic tools (TargetScan, miRDB) were used to construct a circRNA–miRNA–mRNA regulatory network to predict functional pathways.
Results
Microarray analysis identified 132 circRNAs with significantly altered expression in sepsis patients compared to controls (80 upregulated and 52 downregulated). Validation via RT-qPCR confirmed that hsa_circRNA_104484 and hsa_circRNA_104670 were significantly elevated in the serum exosomes of the sepsis group.
ROC analysis demonstrated the diagnostic potential of these markers:
- hsa_circRNA_104484: AUC of 0.782 (Sensitivity: 54.5%, Specificity: 94.7%).
- hsa_circRNA_104670: AUC of 0.775 (Sensitivity: 59.1%, Specificity: 89.5%).
These results suggest that these exosomal circRNAs can distinguish sepsis patients from healthy individuals with moderate to high specificity.
Discussion
The study highlights the role of circRNAs as competing endogenous RNAs (ceRNAs), or "miRNA sponges." By binding to microRNAs, these circRNAs prevent the silencing of target mRNAs, thereby modulating inflammatory gene expression. Bioinformatic modeling linked the identified circRNAs to critical signaling pathways, including PI3K-Akt and MAPK, which are integral to the inflammatory response in sepsis. Specifically, hsa_circRNA_104484 was predicted to interact with miR-378a-3p, a microRNA involved in regulating neutrophil extracellular traps (NETs).
The high stability of exosomal circRNAs compared to linear RNA species enhances their clinical utility as biomarkers. While the AUC values indicate "medium" diagnostic power, these molecular signatures provide a more specific biological insight than traditional clinical markers.
Limitations and Future Directions
Despite the promising findings, several limitations exist. The sample size was relatively small, necessitating larger multi-center studies for validation. Additionally, while bioinformatic analysis suggests regulatory roles, further in vitro and in vivo functional studies are required to elucidate the exact mechanisms by which these circRNAs influence sepsis progression. Future research should also explore the longitudinal changes in these biomarkers to determine their utility in monitoring treatment response and predicting long-term prognosis.
Summary updated